Data gathered: November 22
Alternative Data for Science 37
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 16,000 | Sign up | Sign up | Sign up |
| Google Trends | 28 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 631 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,178 | Sign up | Sign up | Sign up |
| Twitter Mentions | 10 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 331 | Sign up | Sign up | Sign up |
About Science 37
Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.
| Price | $5.75 |
| Target Price | Sign up |
| Volume | 49,100 |
| Market Cap | $35M |
| Year Range | $5.75 - $5.75 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Health Care Services |
In the news
 |
We’re all requesting they do a jumping jack for, y’know… science? (37 Photos)November 13 - Thechive.com |
 |
Research Grid secures $6.5M for AI automation engine for clinical trialsNovember 6 - MobiHealthNews |
 |
Study measures benefits of AI in research, yet highlights potential disparitiesOctober 11 - Digital Journal |
 |
Analysis of approximately 75 million publications finds those employing AI are more likely to be a 'hit paper'October 11 - Phys.Org |
Numerical format and public perception of foreign immigration growth ratesOctober 2 - Plos.org |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '23 | 15M | 29M | -14M | -14M | -3.3M | -0.040 |
| Q2 '23 | 15M | 36M | -20M | -20M | -2.2M | -0.070 |
| Q1 '23 | 14M | 40M | -25M | -25M | -9.6M | -0.110 |
| Q4 '22 | 17M | 81M | -64M | -67M | 29M | -0.140 |
| Q3 '22 | 16M | 37M | -20M | -24M | -22M | -0.170 |
Insider Transactions View All
| Pellizzari Christine A filed to buy 5,000 shares at $0.8. November 17 '22 |
Similar companies
Read more about Science 37 (SNCE) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Science 37?
The Market Cap of Science 37 is $35M.
What is the current stock price of Science 37?
Currently, the price of one share of Science 37 stock is $5.75.
How can I analyze the SNCE stock price chart for investment decisions?
The SNCE stock price chart above provides a comprehensive visual representation of Science 37's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Science 37 shares. Our platform offers an up-to-date SNCE stock price chart, along with technical data analysis and alternative data insights.
Does SNCE offer dividends to its shareholders?
As of our latest update, Science 37 (SNCE) does not offer dividends to its shareholders. Investors interested in Science 37 should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Science 37?
Some of the similar stocks of Science 37 are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.